ATTENTION: Please enable Javascript in your browser for full site functionality.
Skip to navigation Skip to main content Skip to footer

Updates

Clear All

SUB-TYPE:

Vitaflo International Ltd – Dual Agreement

From 6 November 2020, Alliance Healthcare UK will become one of the two wholesalers to supply Vitaflo International Ltd products to all pharmacies, Hospitals, and dispensing doctors in the United Kingdom. The other wholesaler in this agreement is Phoenix.

If you have any queries, please speak to your Alliance Healthcare Account Manager.

SUB-TYPE: CLASS 2 RECALL

Class 2 Recall on Boots Dermacare 1% W/W Hydrocortisone Ointment (P)

The Boots Company PLC has informed us that retained samples of the affected batch showed presence of Pseudomonas aeruginosa and are recalling the above batch as a precautionary measure. This product is only sold or dispensed from Boots stores and Boots online pharmacy.

 

Please visit the: MHRA website for more details on this drug alert.

 

The affected products' details are as follows:

PIP CodeProduct DescriptionSupplierAffected Batch
ALLIANCE DO NOT STOCKBOOTS DERMACARE 1% W/W HYDROCORTISONE OINTMENT (P)THE BOOTS COMPANY PLC1DD

Please note that Alliance do not stock the above product therefore we are not accepting returns on this recall.

For stock control and medical information enquiries please contact 0115 9595165.

Recipients of this Drug Alert should bring it to the attention of relevant contacts.

 

If you have any questions, then please contact your local Service Centre Customer Services team.

SUB-TYPE:

Normal Service Operating Across the Network

SUB-TYPE:

Vitabiotics products now exclusively available to order from Alliance Healthcare

We are pleased to announce that from 1 September 2020, Alliance Healthcare will become the sole wholesaler to supply the Vitabiotics product range of nutrition support and supplements from the UK's number one vitamin company to all pharmacies, hospitals and dispensing doctors in the UK.This is the first solus Health & Beauty OTC agreement in the UK and a very exciting partnership for Alliance Healthcare and Vitabiotics.

 

Purchases of Vitabiotics products will arrive as part of your usual Alliance Healthcare delivery service and willnot be subject to Alliance Healthcare's low spend surcharge, if purchased in isolation. In order to receive the products from 1 September, order from Alliance Healthcare in your usual manner. There will be no changes to the current delivery service for the Vitabiotics product portfolio.

 

If you would like to discuss these changes in more detail, please contact your Alliance Healthcare Account Manager.

 

Click here to purchase your Vitabiotics products through our Alliance Healthcare Portal.  

SUB-TYPE:

Standing shoulder to shoulder

Julian Mount, Managing Director, Alliance Healthcare has been speaking with Pharmacy Business magazine and its editor Priyankur Mandav, about the remarkable way Alliance Healthcare has supported community pharmacy during Covid-19 and operates as the backbone of the NHS.

 

In an exclusive interview with Pharmacy Business magazine, a UK leading pharmacy publication with a print circulation of 10,300, Julian reflects on the remarkable way community pharmacy teams have responded to the Covid-19 pandemic:

 

 "Together with community pharmacy, we are the backbone of the NHS and Alliance Healthcare UK supplies one in every three medicines taken in the UK. 

 

 "We knew we had to do everything possible to ensure medicine supply for UK patients; we certainly embraced the challenge and supported the incredible efforts of community pharmacy, the frontline heroes of the coronavirus pandemic.

 

 "We decided not to furlough our field-based teams to allow us to maintain essential contact with community pharmacy and continue our support. I feel the Covid-19 pandemic has strengthened our already robust relationship and together we have stood shoulder to shoulder with community pharmacy throughout the pandemic, when other healthcare professions closed their doors."

 

Read the guest column here.

SUB-TYPE: CLASS 2 RECALL

Class 2 FMD Recall on Vimpat 100mg Tablets & Neupro 4mg/24 Hour Transdermal Patches

We have been notified of an issue whereby several affected batches of the products from the parallel distributors (repackers) in the link below have been found to have mismatched unique pack numbers on the Bollino label (a security and safety feature on the outer packaging). The unique pack numbers on the bollino label should be identical.

 

Please visit the: MHRA website for more details on this drug alert.

 

The affected products' details are as follows:

.
PIP CodeProduct DescriptionSupplierAffected Batch
8386492PI VIMPAT TAB 100MGVARIOUS, PLEASE REFER TO THE ABOVE LINKVARIOUS, PLEASE REFER TO THE ABOVE LINK
8121238PI NEUPRO PATCHES 4MGVARIOUS, PLEASE REFER TO THE ABOVE LINKVARIOUS, PLEASE REFER TO THE ABOVE LINK
8449324PI VIMPAT TAB 100MGVARIOUS, PLEASE REFER TO THE ABOVE LINKVARIOUS, PLEASE REFER TO THE ABOVE LINK

Further Information BeachCourse Limited For all enquiries please contact:

Julio Iglesias (Site Manager) on 02088969075 or email at julio.bcourse@btconnect.com.

Orifarm A/S For all enquiries please contact:

Paul Tobin (Responsible Person) on 07583577513 or email at paul.tobin@orifarm.com.
Steven Cross (UK Parallel Import Sales Manager) on 07498975920 or email at steven.cross@orifarm.com.

OPD Laboratories Limited For all enquiries please contact:
Vasanth Samson (Quality Assurance Manager/Responsible Person) on 01923332773 or email at vasanth@sigmapl.com.

Strathclyde Pharmaceuticals Limited For all enquiries please contact:
Derek Cochrane (QA Manager) at dcochrane@munro-group.eu.

Quadrant Pharmaceuticals Limited For all enquiries please contact:
Abdul Butt (Director, Quality & QP) on 07838038063 or email at abdul.butt@maxearn.co.uk.


Lexon (UK) Limited For all enquiries please contact:
Yogesh Patel at yogesh.patel@lexonuk.com

Recipients of this Drug Alert should bring it to the attention of relevant contacts.

 

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies. This recall will remain open for 1 month Please note after this date customer returns may still be accepted but customers may not be credited.

If you have any questions, then please contact your local Service Centre Customer Services team.

SUB-TYPE:

Stirling Anglian Pharmaceuticals – Dual Agreement

From 1 October 2020, Alliance Healthcare UK will become one of the two wholesalers to supply Stirling Anglian Pharmaceutical products to all pharmacies, Hospitals, and dispensing doctors in the United Kingdom.

The other wholesaler in this agreement is Phoenix. If you have any queries, please speak to your Alliance Healthcare Account Manager.

SUB-TYPE: CLASS 4 CAUTION IN USE

Class 4 Caution in Use on Zopiclone 3.75mg & 7.5mg Tablets

Ratiopharm UK Limited and Generics [UK] Limited t/a Mylan have confirmed that the Patient Information Leaflet (PIL) within all packs and the Summary of Product Characteristics (SmPC) for Ratiopharm is missing important safety information related to potential suicide risks.

 

Please visit the: MHRA website for more details on this drug alert.

 

The affected products' details are as follows:

PIP CodeProduct DescriptionLiveryAffected Batch

1110980ZOPICLONE TAB 3.75MGRatiopharm UK Limited and Generics [UK] Limited t/a MylanALL STOCK

1073626ZOPICLONE TAB 3.75MGRatiopharm UK Limited and Generics [UK] Limited t/a MylanALL STOCK

1076074ZOPICLONE TAB 3.75MGRatiopharm UK Limited and Generics [UK] Limited t/a MylanALL STOCK

1073584ZOPICLONE TAB 7.5MGGenerics [UK] Limited t/a MylanALL STOCK

1110998ZOPICLONE TAB 7.5MGGenerics [UK] Limited t/a MylanALL STOCK

1073618ZOPICLONE TAB 7.5MGGenerics [UK] Limited t/a MylanALL STOCK

8094740ZOPICLONE TAB 3.75MGRatiopharm UK Limited and Generics [UK] Limited t/a MylanALL STOCK

8094757ZOPICLONE TAB 7.5MGGenerics [UK] Limited t/a MylanALL STOCK

For more information or medical information queries, please contact: Ratiopharm UK Limited Teva UK Medical Information at: medinfo@tevauk.com or Tel No: 0207 540 7117

Generics [UK] Limited t/a Mylan Medical Information Direct Line +44 (0)1707 853 000 select option 1, Customer Care direct lin+44 (0)1707 853 000 select option 2 or via Medical Information e-mail info@mylan.co.uk

Recipients of this Drug Alert should bring it to the attention of relevant contacts.

 

This may have been supplied by AHDL. Unfortunately we are not providing specific batch information you will be required to follow the instructions as per the drug alert.

 

This is a caution in use only we are not accepting stock returns.

 

If you have any questions, then please contact your local Service Centre Customer Services team.

SUB-TYPE: CLASS 3 RECALL

Class 3 Recall on Amlodipine 10mg Tablets

Accord Healthcare Limited is recalling the below batch of Amlodipine 10mg Tablets as a precautionary measure due to out of specification results for tablet description, hardness and average weight obtained during stability testing.

 

Please visit the: MHRA website for more details on this drug alert.

 

The affected products' details are as follows:

PIP CodeProduct DescriptionSupplierAffected Batch
1178177AMLODIPINE TAB 10MGACCORDGY0128
1117969AMLODIPINE TAB 10MGACCORDGY0128
1136175AMLODIPINE TAB 10MGACCORDGY0128
1143353AMLODIPINE TAB 10MGACCORDGY0128
8142705AMLODIPINE TAB 10MGACCORDGY0128

Accord-UK Ltd Medical Information Department Tel: 01271 385257 Email: medinfo@accord-healthcare.com

For stock control enquiries please contact: Accord-UK Ltd Customer Services Team Tel: 0800 373 573

Recipients of this Drug Alert should bring it to the attention of relevant contacts.

 

Please note that Alliance have not supplied the affected batch therefore we are not accepting returns on this recall.

If you have any questions, then please contact your local Service Centre Customer Services team.

SUB-TYPE: CLASS 4 CAUTION IN USE

Class 4 FMD Recall Various products

The MHRA is currently investigating an incident where several medicines appear to have left the legal supply chain and have then been re-introduced via Kingsley Specials Ltd WDA(H) 49276, who purchased from a company that does not hold a wholesale dealers authorisation and then sold it on to a number of other wholesalers.

 

Please visit the: MHRA website for more details on this drug alert.

 

The affected products' details are as follows:

PIP CodeProduct DescriptionSupplierAffected Batch
6839229Pi Eliquis Tabs 2.5mg 60Drugsrus LtdABF5980
ABF6042
ABG1454
ABG1455
ABG1774
ABG1777
ABH0620
ABH0984
ABH4133
ABH4337
ABH4340
ABJ8246
ABJ8737
Alliance have not suppliedEliquis 5 mg film-coated tabletsPlease refer to attached documentPlease refer to attached document
Alliance have not suppliedEntyvio 300 mg powder for concentrate for solution for infusionPlease refer to attached documentPlease refer to attached document
Alliance have not suppliedFlutiform 250 microgram/10 microgram per actuation pressurised inhalation, suspensionPlease refer to attached documentPlease refer to attached document
Alliance have not suppliedPrivigen 20 g - 100 mg/ml solution for infusionPlease refer to attached documentPlease refer to attached document
Alliance have not suppliedSeretide Evohaler 25 microgram/125 microgram per metered dose pressurised inhalation, suspensionPlease refer to attached documentPlease refer to attached document
Alliance have not suppliedSeretide Evohaler 25 microgram/250 microgram per metered dose pressurised inhalation, suspensionPlease refer to attached documentPlease refer to attached document
Alliance have not suppliedStelara 45 mg solution for injection in pre-filled syringePlease refer to attached documentPlease refer to attached document
Alliance have not suppliedStelara 90 mg solution for injection in pre-filled syringePlease refer to attached documentPlease refer to attached document
Alliance have not suppliedStelara 130 mg concentrate for solution for infusionPlease refer to attached documentPlease refer to attached document
Alliance have not suppliedSymbicort® Turbohaler® 200 micrograms/6micrograms inhalation, inhalation powderPlease refer to attached documentPlease refer to attached document
Alliance have not suppliedSynagis 100 mg/1 ml solution for injectionPlease refer to attached documentPlease refer to attached document
Alliance have not suppliedTysabri 300 mg concentrate for solution for infusionPlease refer to attached documentPlease refer to attached document
Alliance have not suppliedZebinix 800mg tabletsPlease refer to attached documentPlease refer to attached document

We will only be accepting Stock returns on PIP 6839229 Pi Eliquis Tabs 2.5mg 60 we are only able to accept stock back that is inactive or stolen stock.

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

Company contacts for further information Smartway Pharmaceuticals Limited • Email: regulatory@smartwaypharma.co.uk • Telephone: 020 8545 7743 Drugsrus Limited • Email: recall@drugsrus.co.uk • Telephone: 020 3397 2347 Optimal Pharma Limited • Email: info@optimalpharma.co.uk • Telephone: 020 3884 0032

 

If you have any questions, then please contact your local Service Centre Customer Services team.